For further details see:
Teva Pharmaceutical falls 6% on eve of Q3 earnings showFor further details see:
Teva Pharmaceutical falls 6% on eve of Q3 earnings showMarket Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
2024-07-13 05:29:00 ET Few pharmaceutical companies are more prominent than Pfizer (NYSE: PFE) and Bristol Myers Squibb (NYSE: BMY) . However, their popularity relative to most of their peers hasn't helped them much in the past few years: Both drugmakers have substantially l...
2024-07-12 11:30:02 ET UBS analyst issues NEUTRAL recommendation for PFE on July 12, 2024 10:19AM ET. The previous analyst recommendation was Neutral. PFE was trading at $29.11 at issue of the analyst recommendation. The overall analyst consensus : HOLD. Current anal...
2024-07-11 08:13:07 ET Pfizer Inc (NYSE: PFE) is in focus today after announcing plans of proceeding with a once-a-day formulation of danuglipron – its weight-loss drug. Encouraging data from an ongoing early-stage study informed its decision to move forward with that variant...